Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 6 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0 trials in Phase 3/4

Results Transparency

33%

1 of 3 completed trials have results

Key Signals

1 with results

Enrollment Performance

Analytics

N/A

4(66.7%)

Phase 1

1(16.7%)

Phase 2

1(16.7%)

6Total

N/A(4)

Phase 1(1)

Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials

NCT04677738Not ApplicableCompleted

Investigation of the Effects of a Bifidobacterium Breve Strain on Fat Loss in Healthy Adults

Role: lead

NCT06686420Not ApplicableActive Not Recruiting

Investigation of the Effects of a Bifidobacterial Strain on Bowel Movement in Healthy Adults

Role: lead

NCT06044376Phase 1Unknown

Ingestion Effect of Formula Milk With Triple Bifidobacteria Strains on Fecal Quality and Metabolites in Healthy Children

Role: collaborator

NCT04565587Not ApplicableUnknown

Dose-response Effect of the Thickener Tsururinko Quickly

Role: lead

NCT02434042Not ApplicableCompleted

Effects of Bifidobacterium Longum BB536 on Incidence of Acute Diarrhea and/or Respiratory- Related Illnesses in Children

Role: collaborator

NCT03318614Phase 2Completed

Bifidobacterium Infantis M-63 Improves Mental Health in Irritable Bowel Syndrome Developed After a Major Flood Disaster

Role: collaborator

All 6 trials loaded